Sistigu et al. [26] demonstrated that anthracyclines elicit aTLR3 signaling cascade in cancer cells that leads to autocrine/paracrine type I IFN signaling and the subsequent secretion of CXCL10 (Figure 4). This evidence concerns the gene CXCL10 and cancer.